HMGA2 and neoplasm: Although there are currently no targeted drugs for HMGA2, in previous clinical trials, we found that inhibiting the expression of HMGA2 with antisense oligonucleotide-modifying enzymes can effectively inhibit the proliferation and malignant transformation of tumor cells.